Functional analysis of zebrafish microfibril-associated glycoprotein-1 (Magp1) in vivo reveals roles for microfibrils

Eleanor Chen1, Jon D Larson, Stephen C Ekker

  • 1Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN 55455, USA.

Blood
|February 14, 2006
PubMed

Insights

Microfibril-associated glycoprotein-1 (MAGP1) is crucial for vascular development and integrity by interacting with fibrillin-1. This finding has implications for cardiovascular tissue engineering and treating vascular diseases.

Area of Science:

  • Vascular Biology
  • Extracellular Matrix Biology
  • Developmental Biology

Background:

  • Mutations in fibrillin-1 (FBN1) cause Marfan syndrome, highlighting microfibrils' importance in vascular health.
  • Many microfibril-associated molecules crucial for vascular development remain uncharacterized.

Purpose of the Study:

  • To identify and characterize novel molecules involved in microfibril formation and vascular development.
  • To investigate the role of Microfibril-associated glycoprotein-1 (MAGP1) in zebrafish embryogenesis and vascular morphogenesis.

Main Methods:

  • A morpholino-based screen was employed to identify key secretome members.
  • Expression analysis of magp1 mRNA and a functional Magp1-mRFP fusion protein.
  • Underexpression and overexpression studies of Magp1 in zebrafish embryos.
  • Assessment of integrin function and Magp1-fibrillin-1 interaction in vivo.

Main Results:

  • MAGP1 was identified as a key player in microfibril formation during zebrafish embryogenesis.
  • Magp1 expression is localized to microfibril-producing cells and the vasculature.
  • Specific Magp1 levels are critical for proper vascular development, with compromised integrin function observed in morphant embryos.
  • MAGP1 directly interacts with fibrillin-1 in vivo.

Conclusions:

  • MAGP1 is essential for microfibril formation, integrity, and vascular morphogenesis.
  • Reduced integrin-matrix interaction is a primary mechanism underlying vascular defects in MAGP1 deficiency.
  • MAGP1 represents a potential therapeutic target for vascular diseases and a target for cardiovascular tissue engineering.

Related Concept Videos